Literature DB >> 21628901

Influence of particle design on oral absorption of poorly water-soluble drug in a silica particle-supercritical fluid system.

Hiroshi Miura1, Makoto Kanebako, Hiroyuki Shirai, Hiroshi Nakao, Toshio Inagi, Katsuhide Terada.   

Abstract

The physicochemical characteristics and oral absorption of a poorly water-soluble drug, K-832, adsorbed onto porous silica (Sylysia 350), were compared with those of K-832 adsorbed onto non-porous silica (Aerosil 200). K-832 and silica were treated with supercritical CO(2) (scCO(2)) to produce K-832-Sylysia 350 and K-832-Aerosil 200 formulations. Scanning electron microscopy, polarizing microscopy, powder X-ray diffraction, and differential scanning calorimetry results suggested that K-832 mainly existed in an amorphous state in both formulations. The specific surface area of both formulations was much larger than that of pure K-832 crystals. The dissolution rate of K-832 from both formulations was considerably greater than that from corresponding physical mixtures due to rapid wetting of the hydrophilic carrier surfaces and amorphous state, the dissolution from the K-832-Sylysia 350 formulation being the fastest. In vivo absorption tests on the two formulations indicated no significant differences in their peak concentration (C(max)) and the area under their plasma concentration-time curve (AUC), while the concentrations of K-832 in the K-832-Sylysia 350 formulation were significantly higher than those in the K-832-Aerosil 200 formulation 1 h and 1.5 h after administration of these formulations (p<0.05). This could be attributed to the different dispersion states of K-832 in the formulations due to their different three-dimensional structures (porous and non-porous). In physical stability tests, the amorphous drugs in both formulations were stable at room temperature for at least 14 months. Thus, the absorption of poorly water-soluble drugs could be greatly improved by adsorption onto porous silica using scCO(2).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628901     DOI: 10.1248/cpb.59.686

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Physicochemical investigations and stability studies of amorphous gliclazide.

Authors:  Shital Jondhale; Satish Bhise; Yogesh Pore
Journal:  AAPS PharmSciTech       Date:  2012-03-02       Impact factor: 3.246

2.  A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica.

Authors:  Frederick G Vogt; Karen Roberts-Skilton; Sonya A Kennedy-Gabb
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.